245
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for treatment of urinary incontinence

, MRCOG, , MD MRCOG & , MD FRCOG
Pages 299-308 | Published online: 13 Apr 2010
 

Abstract

Importance of the field: Urinary incontinence (UI) is a common problem and there are so many advances done in the field to help treat this common and distressing condition.

Areas covered in this review: In this article we have tried to give an overview about current and emerging drugs available for the management of UI.

What the readers gain: Reading the article will help to fill the knowledge gap regarding drugs available for treatment of UI.

Take home message: Anti-muscarinic drugs remain the first-line treatment of overactive bladder (OAB) and a favorable efficacy/tolerability:safety ratio can be confirmed, but adverse effects and decreasing compliance remains an issue. Promising new alternatives are emerging but require further controlled studies to confirm their place in treatment of OAB. Surgery is still the mainstay for treatment of stress incontinence although duloxetine is the only drug licensed for this indication.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,672.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.